Rocket Pharmaceuticals, Inc. Share Price
Equities
RCKT
US77313F1066
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.98 USD | -0.54% | -3.60% | -26.66% |
Sales 2024 * | 29.54M 2.36B | Sales 2025 * | 186M 14.87B | Capitalization | 1.99B 159B |
---|---|---|---|---|---|
Net income 2024 * | -262M -20.97B | Net income 2025 * | -217M -17.37B | EV / Sales 2024 * | 61.8 x |
Net cash position 2024 * | 163M 13.08B | Net cash position 2025 * | 59.29M 4.75B | EV / Sales 2025 * | 10.4 x |
P/E ratio 2024 * |
-8.27
x | P/E ratio 2025 * |
-11.7
x | Employees | 268 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.43% |
Latest transcript on Rocket Pharmaceuticals, Inc.
1 day | -0.54% | ||
1 week | -3.60% | ||
Current month | -18.41% | ||
1 month | -19.34% | ||
3 months | -22.19% | ||
6 months | +23.83% | ||
Current year | -26.66% |
Managers | Title | Age | Since |
---|---|---|---|
Gaurav D. Shah
CEO | Chief Executive Officer | 49 | 03/01/18 |
Kinnari Patel
PSD | President | 46 | 03/01/18 |
Chief Tech/Sci/R&D Officer | 60 | 31/12/15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Pedro Granadillo
BRD | Director/Board Member | 77 | 03/01/18 |
Carsten Boess
BRD | Director/Board Member | 57 | 31/12/15 |
David Southwell
BRD | Director/Board Member | 63 | 31/07/14 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.15% | 2 M€ | -.--% | ||
0.13% | 0 M€ | 0.00% | - | |
0.09% | 0 M€ | 0.00% | - | |
0.06% | 7 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 21.98 | -0.54% | 878,787 |
25/04/24 | 22.1 | -6.47% | 957,992 |
24/04/24 | 23.63 | -0.17% | 918,654 |
23/04/24 | 23.67 | -0.84% | 451,559 |
22/04/24 | 23.87 | +4.69% | 570,571 |
Delayed Quote Nasdaq, April 26, 2024 at 09:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.66% | 1.99B | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- RCKT Stock